Clinical Trials
28 trialsProspective Sample Collection Study for a Blood-Based cfDNA Methylation Assay for Ovarian Cancer Detection
Tongji Hospital
RESO
Zhejiang Cancer Hospital
ConFeR
AbbVie
EORTC QOL-OV39
Helios University Hospital Wuppertal
FORCE
AbbVie
The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients
Far Eastern Memorial Hospital
Visual-PC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance
Tongji Hospital
Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.
National Cancer Institute, Naples
PANtHer-AI
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Efficacy and Safety of Sacituzumab in Patients With OCCC After Immunotherapy Progression
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
COSMOS
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study After the Initial Treatment of Baseline CA125-negative Ovarian Cancer
Shandong University
MISSION-2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Exosome-based Recurrence Score for Post-Treatment Ovarian Cancer
Fudan University
Reproductive Health Outcomes in Young Patients With Ovarian Cancer After Surgical Treatment: A Retrospective Study
Assiut University
High Definition Profiling of Ovarian Cancer Ascites
European Institute of Oncology
The Role of CircDENND4C in Epithelial Ovarian Cancer
Assiut University
Exosome-based OCS Scores for Predicting Ovarian Cancer Recurrence
Peking Union Medical College Hospital
FOFU
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Research and Application of Ultrasonic Intelligent Diagnosis System for Ovarian Mass
Zhejiang Provincial People's Hospital
The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer
Geneplus-Beijing Co. Ltd.
STICRISC
Radboud University Medical Center
To Explore the Feasibility of Dynamic Changes of TCR Diversity in Peripheral Blood in Monitoring Recurrence and Evaluating Prognosis of Epithelial Ovarian Cancer
The First Hospital of Jilin University
SUMMER
Imperial College London
The Correlation Between HRD Detection and the Efficacy of PARP Inhibitors in Ovarian Cancer
Fujian Cancer Hospital
Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients
Power Life Sciences Inc.
The Effectiveness of Liquid Biopsy in Differential Diagnosis and Early Screening of Epithelial Ovarian Cancer
Peking Union Medical College Hospital